Massachusetts is currently home to 3377 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Boston, Worcester, Springfield and Burlington. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
A Mobile Tai Chi Platform for Fall Prevention and Cognition in Older Adults
Recruiting
The investigators will assess feasibility and acceptability of the Tele-Tai Chi (TC) intervention; explore changes in clinically relevant outcome measures including: physical activity, self-efficacy, quality of life, cognitive function, balance, gait, and evaluate changes in TC proficiency. To achieve this, the investigators are running a single-arm study for older adults that involves a 12-week home-based Tai Chi intervention. Study participation includes four remote and/or in-person (at Spauld... Read More
Gender:
All
Ages:
Between 60 years and 85 years
Trial Updated:
10/25/2022
Locations: Spaulding Rehabilitation Hospital, Boston, Massachusetts
Conditions: Aging, Fall
Influence of Body Weight and Composition on Immune Recovery
Recruiting
Immune dysfunction in individuals with obesity, secondary to chronic inflammation, may have an acute impact on War fighter health and readiness, and subsequent lethality. Indeed, ~51% of military personnel ages 17 or older are overweight, and ~15% have obesity (ranging from 6.4% in the Marine Corps to 18.0% in the Army). In conjunction with in vitro functional tests to assess systemic immune function, the suction blister model is a minimally invasive procedure that allows in vivo assessment of i... Read More
Gender:
All
Ages:
Between 18 years and 39 years
Trial Updated:
10/25/2022
Locations: U.S. Army Research Institute of Environmental Medicine, Natick, Massachusetts
Conditions: BMI/Body Composition
Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa
Recruiting
Study PTM-001-01 is a 12-week, randomized, placebo controlled, double blind study with a 12 week open-label extension to examine the immunomodulatory activity of PTM-001 in participants with Hidradenitis Suppurativa (HS). Participants will be randomized to receive PTM-001 (400 mg) or matching placebo every day for 12 weeks after which all participants will receive open-label PTM-001 400 mg daily for an additional 12 weeks. Randomization will be stratified by Hurley Stage.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/24/2022
Locations: Phoenicis Investigative Site, Worcester, Massachusetts
Conditions: Hidradenitis Suppurativa
Effects of Varying Energy Deficits on Protein Turnover at Rest and Carbohydrate Oxidation During Steady-state Exercise
Recruiting
This randomized, parallel study will examine the effects of energy balance and varying magnitudes of energy deficit on 1) the protein kinetic responses to consuming high quality protein and 2) carbohydrate oxidation during steady-state exercise. Healthy adults, representative of active duty military personnel, will complete a 2 d energy balance phase followed by a randomly assigned, 5 d energy deficit phase (n=15 per group; 20%, 40% and 60% energy deficit). At the end of each energy phase the ef... Read More
Gender:
All
Ages:
Between 18 years and 35 years
Trial Updated:
10/24/2022
Locations: US Army Research Institute of Environmental Medicine, Natick, Massachusetts
Conditions: Energy Supply; Deficiency, Severe, Energy Supply; Deficiency, Stress, Physiological
TCF-001 TRACK (Target Rare Cancer Knowledge) Study
Recruiting
This open label, non-randomized, multi-center, pragmatic study aims to establish whether patients with rare tumors can benefit from matched molecular therapy as dictated by their next-generation sequencing (NGS) results.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/21/2022
Locations: TargetCancer Foundation, Cambridge, Massachusetts
Conditions: Rare Cancers, Cholangiocarcinoma, Cancer of Unknown Primary Site
CERENOVUS Neurothrombectomy Devices Registry
Recruiting
A post-market registry evaluating the EmboTrap® Revascularization Device and CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter in acute ischemic stroke patients with confirmed intracranial large vessel occlusion.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/19/2022
Locations: University of Massachusetts, Worcester, Massachusetts
Conditions: Cerebral Stroke
XACT ACE Observational Registry
Recruiting
Compile real world data on the use of the XACT ACE Robotic System
Gender:
All
Ages:
18 years and above
Trial Updated:
10/18/2022
Locations: Lahey Hospital and Medical Center, Burlington, Massachusetts
Conditions: Tumors
Transplanting Hepatitis C Positive Organs
Recruiting
This is an open-label, pilot safety and efficacy trial for adults who are active on the heart, lung, or kidney transplantation lists and are eligible to receive an organ from an increased risk donor who has evidence of active or prior hepatitis C infection (HCV).
Gender:
All
Ages:
18 years and above
Trial Updated:
10/10/2022
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Hepatitis C, Awaiting Organ Transplant
Clinical Trial Comparing Two Non-Surgical Treatments for Severe Blepharoptosis
Recruiting
This clinical trial will evaluate two non-surgical devices designed to improve eye lid opening for patients with severe Blepharoptosis (incomplete opening of the eyelids).
Gender:
All
Ages:
5 years and above
Trial Updated:
10/07/2022
Locations: Massachusetts Eye and Ear, Boston, Massachusetts
Conditions: Blepharoptosis, Ptosis, Eyelid, Myasthenia Gravis, Stroke, Traumatic Brain Injury, Chronic Progressive External Ophthalmoplegia
The Genomic Medicine at VA Study
Recruiting
This trial will determine the clinical effectiveness of polygenic risk score testing among patients at high genetic risk for at least one of six diseases (coronary artery disease, atrial fibrillation, type 2 diabetes mellitus, colorectal cancer, breast cancer, or prostate cancer), measured by time-to-diagnosis of prevalent or incident disease over 24 months.
Gender:
All
Ages:
Between 50 years and 70 years
Trial Updated:
09/29/2022
Locations: VA Boston Healthcare System, Boston, Massachusetts
Conditions: Coronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes, Colorectal Cancer, Breast Cancer, Prostate Cancer
Remote Monitoring of High-Risk Patients With Chronic Cardiopulmonary Diseases
Recruiting
In this project, Institute of Bioengineering & Bioimaging (IBB), A*STAR would like to collaborate with Massachusetts General Hospital to aggregate patient data and to further develop its software algorithm using machine learning and statistical models for predicting exacerbations and deterioration on 60 patients with cardiopulmonary diseases.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/27/2022
Locations: Integrated Care Management Program, Boston, Massachusetts
Conditions: Congestive Heart Failure, Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis
Effectiveness of a Walking Intervention on Impact Loading and Pain
Recruiting
This study investigates the feasibility of a gait-retraining program for older adults with knee osteoarthritis. The study will enroll 40 participants, with 20 receiving a gait retraining intervention and 20 receiving a graded walking program without gait retraining.
Gender:
All
Ages:
45 years and above
Trial Updated:
09/27/2022
Locations: Northeastern University, Boston, Massachusetts
Conditions: Osteoarthritis, Knee, Knee Pain Chronic